Panel Urges Further Research to Determine which DCIS Patients may be Candidates for Less-Invasive Therapy – 2
Narrator: This is NIH Health Matters. Ductal carcinoma in situ, or DCIS, is the most common non-invasive breast lesion. Dr. Carmen Allegra, from the University of Florida says it presents unique challenges for patients and health providers.
Dr. Allegra: We do not understand the natural history of DCIS, and probably never will. And thatís primarily because just about every one who is diagnoses with DCIS undergoes some form of therapy in general that leads to surgical intervention.
Narrator: An independent panel, chaired by Dr. Allegra, is urging more research to determine which DCIS patients may be candidates for less-invasive therapy. For more information, visit the website consensus.nih.gov. Health Matters is produced by the National Institutes of Health, part of the US Department of Health and Human Services.
About NIH Radio
NIH Radio offers free audio news programs from the National Institutes of Health, your reliable source for health information.
All NIH Radio content is in the public domain and can be used without charge or restriction provided that it is not used to misrepresent our agency nor used to suggest we endorse any private organization, product, or service.
NIH Radio is a service of the Office of Communications & Public Liaison.